An overview of current and emerging antifungal pharmacotherapy for invasive fungal infections

Mueller Scott W.; Kedzior Sonya K.; Miller Matthew A.Reynolds Paul M.Kiser Tyree H.Krsak MartinMolina Kyle C.

首页> 外文期刊>Expert opinion on pharmacotherapy >An overview of current and emerging antifungal pharmacotherapy for invasive fungal infections

【24h】

An overview of current and emerging antifungal pharmacotherapy for invasive fungal infections

机译：An overview of current and emerging antifungal pharmacotherapy for invasive fungal infections

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相关主题

摘要

Introduction: Invasive fungal infections (IFIs) remain a significant cause of morbidity and mortality despite significant advancements in currently available therapy. With a flush pipeline of investigational antifungals, the clinician must identify appropriate roles of currently available therapies, potential advantages of emerging antifungals, and shortcomings in the evolving clinical evidence.

著录项

来源
《Expert opinion on pharmacotherapy》 |2021年第12期|1355-1371|共17页
作者
Mueller Scott W.; Kedzior Sonya K.; Miller Matthew A.Reynolds Paul M.Kiser Tyree H.Krsak MartinMolina Kyle C.;
展开▼
作者单位

Univ Colorado, Skaggs Sch Pharm & Pharmaceut Sci, Dept Clin Pharm, Aurora, CO 80045 USA;

Univ Colorado Hosp, Dept Pharm, Aurora, CO 80045 USA;

Univ Colorado, Sch Med, Div Infect Dis, Dept Med, Aurora, CO USA;

展开▼
收录信息
原文格式 PDF
正文语种英语
中图分类药学;
关键词
Antifungals; aspergillosis; candidiasis; invasive fungal infections; novel antifungal therapies; pipeline; review;

An overview of current and emerging antifungal pharmacotherapy for invasive fungal infections

摘要

著录项

相关主题

期刊订阅